At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
AAVXF Abivax SA
Market Closed 04-17 16:00:00 EDT Delay
Abivax publishes financial reports with the French and U.S. securities regulatory agencies
GlobeNewswire  ·  03-26
Abivax publishes financial reports with the French and U.S. securities regulatory agencies
Abivax SA’s Obefazimod: A Promising Blockbuster in Ulcerative Colitis Treatment
TIPRANKS  ·  03-25
Abivax SA’s Obefazimod: A Promising Blockbuster in Ulcerative Colitis Treatment
Buy Rating for Abivax SA Driven by Promising Obefazimod Data and Market Potential
TIPRANKS  ·  03-19
Buy Rating for Abivax SA Driven by Promising Obefazimod Data and Market Potential
Abivax SA Sponsored ADR (ABVX) Gets a Buy from Piper Sandler
TIPRANKS  ·  03-10
Abivax SA Sponsored ADR (ABVX) Gets a Buy from Piper Sandler
Kepler Capital Reaffirms Their Buy Rating on Abivax SA (0RA9)
TIPRANKS  ·  02-13
Kepler Capital Reaffirms Their Buy Rating on Abivax SA (0RA9)
Piper Sandler Sticks to Their Buy Rating for Abivax SA Sponsored ADR (ABVX)
TIPRANKS  ·  02-10
Piper Sandler Sticks to Their Buy Rating for Abivax SA Sponsored ADR (ABVX)
Morgan Stanley Sticks to Its Hold Rating for Abivax SA Sponsored ADR (ABVX)
TIPRANKS  ·  01-28
Morgan Stanley Sticks to Its Hold Rating for Abivax SA Sponsored ADR (ABVX)
Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress
GlobeNewswire  ·  01-23
Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress
Kepler Capital Sticks to Their Buy Rating for Abivax SA (0RA9)
TIPRANKS  ·  01-12
Kepler Capital Sticks to Their Buy Rating for Abivax SA (0RA9)
Analysts Offer Insights on Healthcare Companies: IGM Biosciences (IGMS) and Abivax SA Sponsored ADR (ABVX)
TIPRANKS  ·  01-10
Analysts Offer Insights on Healthcare Companies: IGM Biosciences (IGMS) and Abivax SA Sponsored ADR (ABVX)
Abivax SA: Strong Progress in Phase 3 Trials and Solid Financial Position Justify Buy Rating
TIPRANKS  ·  01-09
Abivax SA: Strong Progress in Phase 3 Trials and Solid Financial Position Justify Buy Rating
Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment
GlobeNewswire  ·  01-09
Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment
Abivax SA Sponsored ADR (ABVX) Gets a Buy from JMP Securities
TIPRANKS  ·  2024-12-05
Abivax SA Sponsored ADR (ABVX) Gets a Buy from JMP Securities
BRIEF-Abivax SA Files For Mixed Shelf Of Up To $350 Million - SEC Filing
Reuters  ·  2024-11-19
BRIEF-Abivax SA Files For Mixed Shelf Of Up To $350 Million - SEC Filing
Abivax SA Ends Liquidity Contract, Reports Cash Balance
TIPRANKS  ·  2024-10-11
Abivax SA Ends Liquidity Contract, Reports Cash Balance
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Abivax SA Sponsored ADR (ABVX) and Aquestive Therapeutics (AQST)
TIPRANKS  ·  2024-10-08
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Abivax SA Sponsored ADR (ABVX) and Aquestive Therapeutics (AQST)
Kepler Capital Reaffirms Their Buy Rating on Abivax SA (0RA9)
TIPRANKS  ·  2024-10-06
Kepler Capital Reaffirms Their Buy Rating on Abivax SA (0RA9)
Buy Rating for Abivax SA Amid Sustained Efficacy and Safety of Obefazimod
TIPRANKS  ·  2024-10-03
Buy Rating for Abivax SA Amid Sustained Efficacy and Safety of Obefazimod

Introduction

Company Name.
Abivax SA
Affiliated Markets:
PINK LIMITED
Listing Date:
--
Main Business:
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
Issue price:
--
Invest in Global Markets with Tiger Brokers!
Open App